Evidence map›Paper›PMID 27919184›Full record

ArticleInhalation toxicology2016

Role of engineered metal oxide nanoparticle agglomeration in reactive oxygen species generation and cathepsin B release in NLRP3 inflammasome activation and pulmonary toxicity.

Tina M Sager, Michael Wolfarth, Stephen S Leonard, Anna M Morris, Dale W Porter, Vincent Castranova, Andrij Holian

Open access · greenAbstract read
In one paragraph

Article in Inhalation toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. BioMed research international · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Tina M Sagera Center for Environmental Health Sciences, University of Montana , Missoula , MT , USA.
Michael Wolfarthb Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health , Morgantown , WV , USA , and.
Stephen S Leonardb Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health , Morgantown , WV , USA , and.
Anna M Morrisb Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health , Morgantown , WV , USA , and.
Dale W Porterb Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health , Morgantown , WV , USA , and.
Vincent Castranovab Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health , Morgantown , WV , USA , and.
Andrij Holiana Center for Environmental Health Sciences, University of Montana , Missoula , MT , USA.
National Institute for Occupational Safety and Health · USCenter for Environmental Health · USUniversity of Montana · USWest Virginia University · US

Funding

Effects of nanoparticle dispersion status on bioactivity and translocation in theF32ES021341 · NIEHS · UNIVERSITY OF MONTANA · PI SAGER, TINA MARIE · 2013 to 2015
$183k
NIEHS NIH HHS F32 ES021341
6 · The paper itself

Abstract

Incomplete understanding of the contributions of dispersants and engineered nanoparticles/materials (ENM) agglomeration state to biological outcomes presents an obstacle for toxicological studies. Although reactive oxygen species (ROS) production is often regarded as the primary indicator of ENM bioactivity and toxicity, it remains unclear whether ENM produce ROS or whether ROS is an outcome of ENM-induced cell injury. Phagolysosomal disruption and cathepsin B release also promote bioactivity through inflammasome activation. Therefore, specific particle parameters, i.e. preexposure dispersion status and particle surface area, of two ENM (NiO and CeO

Indexed as

AnimalsBronchoalveolar Lavage FluidCathepsin BCell CountCeriumInflammasomesInterleukin-18Interleukin-1betaL-Lactate DehydrogenaseLungMaleMetal NanoparticlesMice, Inbred C57BLNickelNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesCathepsin Bceric oxideCeriumCtsb protein, mouseIL1B protein, mouseInflammasomesInterleukin-18Interleukin-1betaL-Lactate DehydrogenaseNickelnickel monoxideNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseReactive Oxygen Speciesactivationagglomerationcytotoxicityengineered nanoparticlesinflammasomeinflammationpulmonary toxicityROS

Identifiers

PMID27919184
PMCPMC5558090
OpenAlexW2560355562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.